PTNS Versus Sham Efficacy in Treatment of BPS
Status: | Recruiting |
---|---|
Conditions: | Urology, Urology |
Therapuetic Areas: | Nephrology / Urology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/26/2018 |
Start Date: | June 2016 |
End Date: | March 2019 |
Contact: | Dominique Malacarne |
Email: | malacd01@nyumc.org |
Randomized Controlled Trial of PTNS Versus Sham Efficacy in Treatment of Bladder Pain Syndrome
This is a prospective, single center, double-blind, randomized, controlled trial comparing
the efficacy of percutaneous tibial nerve stimulation to sham in the treatment of Bladder
Pain Syndrome/Interstitial Cystitis (BPS/IC) through 12 weeks of therapy.
the efficacy of percutaneous tibial nerve stimulation to sham in the treatment of Bladder
Pain Syndrome/Interstitial Cystitis (BPS/IC) through 12 weeks of therapy.
This is a pilot study to evaluate the efficacy of the systematic effects of posterior tibial
nerve stimulation (PTNS) treatment compared to an inactive sham intervention in female
subjects with interstitial cystitis/bladder pain syndrome (IC/BPS) in an intent-to-treat
analysis. The primary outcome measure will be the Patient Global Impression of Improvement
(PGI-I) a single item questionnaire assessing overall impression of improvement over time at
the initial 12 weeks endpoint.
It is hypothesized that subjects randomized to the PTNS arm will demonstrate a greater
improvement in both pain and quality of life scores, when compared with subjects who are
randomized to the sham arm.
nerve stimulation (PTNS) treatment compared to an inactive sham intervention in female
subjects with interstitial cystitis/bladder pain syndrome (IC/BPS) in an intent-to-treat
analysis. The primary outcome measure will be the Patient Global Impression of Improvement
(PGI-I) a single item questionnaire assessing overall impression of improvement over time at
the initial 12 weeks endpoint.
It is hypothesized that subjects randomized to the PTNS arm will demonstrate a greater
improvement in both pain and quality of life scores, when compared with subjects who are
randomized to the sham arm.
Inclusion Criteria:
- Women ≥18 years old with visual analog scale > 5
- Cessation of all analgesics or other medication for pain for at least 2 weeks prior to
the PTNS intervention
- Discontinuation of any other electrical stimulation methods for 3 months prior to PTNS
intervention.
- Capable of giving informed consent
- Ambulatory
- Capable and willing to follow all study-relation procedures
Exclusion Criteria:
- Patients pregnant or planning to become pregnant during the study duration
- Botox use in pelvic floor muscles within the last year
- Current urinary or vaginal infections
- Current use of Interstim device
- History of a cardiac pacemaker
- Diagnosis of neuropathy
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Benjamin Brucker, MD
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials